2. Academic Validation
  3. ARIH1 inhibits influenza A virus replication and facilitates RIG-I dependent immune signaling by interacting with SQSTM1/p62

ARIH1 inhibits influenza A virus replication and facilitates RIG-I dependent immune signaling by interacting with SQSTM1/p62

  • Virol J. 2023 Apr 1;20(1):58. doi: 10.1186/s12985-023-02022-1.
Shengyu Wang # 1 2,  Zhenrong Li # 2,  Yaping Chen # 2,  Sanli Gao 1 2,  Junhua Qiao 2,  Haoru Liu 2,  Hong Song 2,  Dishu Ao 2,  Xin Sun 3 4
Affiliations

Affiliations

  • 1 Key Laboratory of Infectious Disease and Biosafety, Provincial Department of Education, Guizhou, Institute of Life Sciences/ College of Preclinical Medicine, Zunyi Medical University, Zunyi, China.
  • 2 Department of Microbiology, College of Preclinical Medicine, Zunyi Medical University, Zunyi, China.
  • 3 Key Laboratory of Infectious Disease and Biosafety, Provincial Department of Education, Guizhou, Institute of Life Sciences/ College of Preclinical Medicine, Zunyi Medical University, Zunyi, China. coolxin@foxmail.com.
  • 4 Department of Microbiology, College of Preclinical Medicine, Zunyi Medical University, Zunyi, China. coolxin@foxmail.com.
  • # Contributed equally.
PMID: 37005687 DOI: 10.1186/s12985-023-02022-1
Abstract

Background: Multiple host factors are involved in modulating type I interferon expression induced by viruses; however, the mechanism is not fully elucidated. Influenza A virus Infection causes severe respiratory symptoms and triggers a series of signaling cascades and host innate immune responses, including interferon production. The co-IP/MS technology was used to screen several Antiviral factors in the early stage. Among these factors, ariadne-1 homolog (ARIH1) caught our attention.

Methods: Western blot assay was performed to detect the level of proteins and software ImageJ was used to analyze the band intensities. Polymerase activity assay was conducted to evaluate the polymerase activity of influenza A virus. Tissue culture infective dose (TCID50) assay was performed to measure influenza A virus titers, and quantitative RT-PCR assay was applied to test the mRNA level of IFN-β, ISG56, and CXCL10. Luciferase reporter assay was used to confirm the target of ARIH1 in RIG-I signaling. Immunoprecipitation assay was performed to detect the interaction and the ubiquitination of the proteins. All data were analyzed by biostatistical methods and presented as means ± standard deviation from three independent experiments. Statistical significance was determined using two-tailed student's t test. A P value of less than 0.05 was considered statistically significant, and a P value of less than 0.01 was considered highly significant (ns, P ≥ 0.05; *, P < 0.05; and **, P < 0.01).

Results: We found that ARIH1, a member of E3 ubiquitin ligases, enhanced cellular Antiviral responses. Subsequent study showed that ARIH1 was up-regulated during influenza A virus Infection. Further analysis showed that ARIH1 enhanced IFN-β and downstream gene expression by affecting the degradation of RIG-I through the SQSTM1/p62 signaling pathway.

Conclusion: This newly revealed mechanism shows that cellular response increases of ARIH1 and promotes IFN-β expression to boost host survival during viral Infection.

Keywords

ARIH1; Influenza A virus; Innate immunity; RIG-I; SQSTM1; p62.

Figures
Products